Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease
Chronic liver disease (CLD) represents a global health problem, accounting for the heavy burden of disability and increased health care utilization. Epigenome alterations play an important role in the occurrence and progression of CLD. Histone modifications, which include acetylation, methylation, a...
Saved in:
Main Authors: | Qiuyu Cai (Author), Can Gan (Author), Chengwei Tang (Author), Hao Wu (Author), Jinhang Gao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
by: Jiaxin Chen, et al.
Published: (2024) -
Atypical cholangiocytes derived from hepatocyte-cholangiocyte transdifferentiation mediated by COX-2: a kind of misguided liver regeneration
by: Tian Lan, et al.
Published: (2023) -
Mechanical Cues Regulate Histone Modifications and Cell Behavior
by: Buwei Hu, et al.
Published: (2022) -
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
by: Jianwei Feng, et al.
Published: (2022) -
The Histone Modification Code in the Pathogenesis of Autoimmune Diseases
by: Yasuto Araki, et al.
Published: (2017)